4-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide → 4-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([O:32][C:33]2[CH:38]=[C:37]([F:39])[C:36]([S:40](=[O:59])(=[O:58])[N:41](CC3C=CC(OC)=CC=3OC)[C:42]3[S:46][N:45]=[CH:44][N:43]=3)=[CH:35][C:34]=2[F:60])=[C:6]([C:8]2[CH:9]=[CH:10][C:11]3[O:15][N:14]=[C:13]([N:16]([C:24](OC(C)(C)C)=O)[C:17](OC(C)(C)C)=O)[C:12]=3[CH:31]=2)[CH:7]=1.ClC1C=CC(OC2C(F)=CC(S(N(CC3C=CC(OC)=CC=3OC)C3SN=CN=3)(=O)=O)=C(F)C=2)=C(C2C=CC3ON=C(N(C)C)C=3C=2)C=1>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([O:32][C:33]2[C:34]([F:60])=[CH:35][C:36]([S:40]([NH:41][C:42]3[S:46][N:45]=[CH:44][N:43]=3)(=[O:59])=[O:58])=[C:37]([F:39])[CH:38]=2)=[C:6]([C:8]2[CH:9]=[CH:10][C:11]3[O:15][N:14]=[C:13]([N:16]([CH3:17])[CH3:24])[C:12]=3[CH:31]=2)[CH:7]=1Participants
Reactant 2
Product 1
Procedure
Following the procedure as described in EXAMPLE 44, making non-critical variations to replace di-tert-butyl [5-(5-chloro-2-{4-[(2,4-dimethoxybenzyl)(1,2,4-thiadiazol-5-yl)sulfamoyl]-2,5-difluorophenoxy}phenyl)-1,2-benzoxazol-3-yl]imidodicarbonate with 4-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-N-(2,4-dimethoxybenzyl)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide, 4-(4-chloro-2-(3-(dimethylamino)benzo[d]isoxazol-5-yl)phenoxy)-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide was obtained as a colorless solid in 31% yield (0.06 g): 1H NMR (300 MHz, DMSO-d6) δ8.53 (s, 1H), 8.03 (d, J=1.1 Hz, 1H), 7.74-7.68 (m, 2H), 7.66 (dd, J=8.7, 1.6 Hz, 1H), 7.56 (d, J=8.9 Hz, 1H), 7.52 (dd, J=8.8, 2.7 Hz, 1H), 7.32 (d, J=8.7 Hz, 1H), 7.13 (dd, J=10.5, 6.5 Hz, 1H), 3.08 (s, 6H); MS (ES+) m/z 563.6 (M+1), 565.6 (M+1).
Sources & evidence
- ORD record
- ord-a712073dd0cf49e3bdfc0b5510bfb8d1
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09365578B2
Reaction notes
Loading…